ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mesalamine Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-27A8791
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mesalamine Market Outlook 2022
BUY CHAPTERS

Global Mesalamine Market Research Report 2024

Code: QYRE-Auto-27A8791
Report
September 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Syntese A/S
Divis Laboratories
Ipca Laboratories
Hangzhou Brother
PharmaZell GmbH
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Cambrex Corporation
Chemi SPA

Mesalamine Market Size

The global Mesalamine market was valued at US$ 180 million in 2023 and is anticipated to reach US$ 231 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.

Mesalamine Market

Mesalamine Market

Mesalamine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine.
The Mesalamine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Mesalamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mesalamine Market Report

Report Metric Details
Report Name Mesalamine Market
Accounted market size in 2023 US$ 180 million
Forecasted market size in 2030 US$ 231 million
CAGR 3.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Purity ≥ 97%
  • Purity ≥ 98%
  • Purity ≥ 99%
Segment by Application
  • Tablets
  • Capsules
  • Granule
  • Suppository
  • Enema
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mesalamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Mesalamine Market growing?

Ans: The Mesalamine Market witnessing a CAGR of 3.7% during the forecast period 2024-2030.

What is the Mesalamine Market size in 2030?

Ans: The Mesalamine Market size in 2030 will be US$ 231 million.

What is the market share of major companies in Mesalamine Market?

Ans: The top 3 companies hold a share over 50%.

What is the Mesalamine Market share by region?

Ans: Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Who are the main players in the Mesalamine Market report?

Ans: The main players in the Mesalamine Market are PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical

What are the Application segmentation covered in the Mesalamine Market report?

Ans: The Applications covered in the Mesalamine Market report are Tablets, Capsules, Granule, Suppository, Enema, Others

What are the Type segmentation covered in the Mesalamine Market report?

Ans: The Types covered in the Mesalamine Market report are Purity ≥ 97%, Purity ≥ 98%, Purity ≥ 99%

1 Mesalamine Market Overview
1.1 Product Definition
1.2 Mesalamine by Type
1.2.1 Global Mesalamine Market Value Comparison by Type (2024-2030)
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Mesalamine by Application
1.3.1 Global Mesalamine Market Value by Application (2024-2030)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Mesalamine Market Size Estimates and Forecasts
1.4.1 Global Mesalamine Revenue 2019-2030
1.4.2 Global Mesalamine Sales 2019-2030
1.4.3 Global Mesalamine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mesalamine Market Competition by Manufacturers
2.1 Global Mesalamine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mesalamine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mesalamine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Mesalamine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mesalamine, Product Type & Application
2.7 Global Key Manufacturers of Mesalamine, Date of Enter into This Industry
2.8 Global Mesalamine Market Competitive Situation and Trends
2.8.1 Global Mesalamine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mesalamine Players Market Share by Revenue
2.8.3 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mesalamine Market Scenario by Region
3.1 Global Mesalamine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mesalamine Sales by Region: 2019-2030
3.2.1 Global Mesalamine Sales by Region: 2019-2024
3.2.2 Global Mesalamine Sales by Region: 2025-2030
3.3 Global Mesalamine Revenue by Region: 2019-2030
3.3.1 Global Mesalamine Revenue by Region: 2019-2024
3.3.2 Global Mesalamine Revenue by Region: 2025-2030
3.4 North America Mesalamine Market Facts & Figures by Country
3.4.1 North America Mesalamine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mesalamine Sales by Country (2019-2030)
3.4.3 North America Mesalamine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mesalamine Market Facts & Figures by Country
3.5.1 Europe Mesalamine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mesalamine Sales by Country (2019-2030)
3.5.3 Europe Mesalamine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesalamine Market Facts & Figures by Region
3.6.1 Asia Pacific Mesalamine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mesalamine Sales by Region (2019-2030)
3.6.3 Asia Pacific Mesalamine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mesalamine Market Facts & Figures by Country
3.7.1 Latin America Mesalamine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mesalamine Sales by Country (2019-2030)
3.7.3 Latin America Mesalamine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mesalamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesalamine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mesalamine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mesalamine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mesalamine Sales by Type (2019-2030)
4.1.1 Global Mesalamine Sales by Type (2019-2024)
4.1.2 Global Mesalamine Sales by Type (2025-2030)
4.1.3 Global Mesalamine Sales Market Share by Type (2019-2030)
4.2 Global Mesalamine Revenue by Type (2019-2030)
4.2.1 Global Mesalamine Revenue by Type (2019-2024)
4.2.2 Global Mesalamine Revenue by Type (2025-2030)
4.2.3 Global Mesalamine Revenue Market Share by Type (2019-2030)
4.3 Global Mesalamine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mesalamine Sales by Application (2019-2030)
5.1.1 Global Mesalamine Sales by Application (2019-2024)
5.1.2 Global Mesalamine Sales by Application (2025-2030)
5.1.3 Global Mesalamine Sales Market Share by Application (2019-2030)
5.2 Global Mesalamine Revenue by Application (2019-2030)
5.2.1 Global Mesalamine Revenue by Application (2019-2024)
5.2.2 Global Mesalamine Revenue by Application (2025-2030)
5.2.3 Global Mesalamine Revenue Market Share by Application (2019-2030)
5.3 Global Mesalamine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 PharmaZell
6.1.1 PharmaZell Company Information
6.1.2 PharmaZell Description and Business Overview
6.1.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 PharmaZell Mesalamine Product Portfolio
6.1.5 PharmaZell Recent Developments/Updates
6.2 Syntese A/S
6.2.1 Syntese A/S Company Information
6.2.2 Syntese A/S Description and Business Overview
6.2.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Syntese A/S Mesalamine Product Portfolio
6.2.5 Syntese A/S Recent Developments/Updates
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Company Information
6.3.2 Cambrex Corporation Description and Business Overview
6.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cambrex Corporation Mesalamine Product Portfolio
6.3.5 Cambrex Corporation Recent Developments/Updates
6.4 Divis Laboratories
6.4.1 Divis Laboratories Company Information
6.4.2 Divis Laboratories Description and Business Overview
6.4.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Divis Laboratories Mesalamine Product Portfolio
6.4.5 Divis Laboratories Recent Developments/Updates
6.5 Chemi SpA
6.5.1 Chemi SpA Company Information
6.5.2 Chemi SpA Description and Business Overview
6.5.3 Chemi SpA Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chemi SpA Mesalamine Product Portfolio
6.5.5 Chemi SpA Recent Developments/Updates
6.6 Ipca Laboratories
6.6.1 Ipca Laboratories Company Information
6.6.2 Ipca Laboratories Description and Business Overview
6.6.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ipca Laboratories Mesalamine Product Portfolio
6.6.5 Ipca Laboratories Recent Developments/Updates
6.7 Hangzhou Brother
6.7.1 Hangzhou Brother Company Information
6.7.2 Hangzhou Brother Description and Business Overview
6.7.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hangzhou Brother Mesalamine Product Portfolio
6.7.5 Hangzhou Brother Recent Developments/Updates
6.8 Lianyungang Fengheng Biopharm
6.8.1 Lianyungang Fengheng Biopharm Company Information
6.8.2 Lianyungang Fengheng Biopharm Description and Business Overview
6.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lianyungang Fengheng Biopharm Mesalamine Product Portfolio
6.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
6.9 Lasa Loboratory
6.9.1 Lasa Loboratory Company Information
6.9.2 Lasa Loboratory Description and Business Overview
6.9.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lasa Loboratory Mesalamine Product Portfolio
6.9.5 Lasa Loboratory Recent Developments/Updates
6.10 Corden Pharma Bergamo
6.10.1 Corden Pharma Bergamo Company Information
6.10.2 Corden Pharma Bergamo Description and Business Overview
6.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Corden Pharma Bergamo Mesalamine Product Portfolio
6.10.5 Corden Pharma Bergamo Recent Developments/Updates
6.11 Erregierre SpA
6.11.1 Erregierre SpA Company Information
6.11.2 Erregierre SpA Description and Business Overview
6.11.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Erregierre SpA Mesalamine Product Portfolio
6.11.5 Erregierre SpA Recent Developments/Updates
6.12 CTX Lifescience
6.12.1 CTX Lifescience Company Information
6.12.2 CTX Lifescience Description and Business Overview
6.12.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CTX Lifescience Mesalamine Product Portfolio
6.12.5 CTX Lifescience Recent Developments/Updates
6.13 Ishita Active Pharma Ingredients
6.13.1 Ishita Active Pharma Ingredients Company Information
6.13.2 Ishita Active Pharma Ingredients Description and Business Overview
6.13.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Ishita Active Pharma Ingredients Mesalamine Product Portfolio
6.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
6.14 YC Biotech (Jiangsu)
6.14.1 YC Biotech (Jiangsu) Company Information
6.14.2 YC Biotech (Jiangsu) Description and Business Overview
6.14.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 YC Biotech (Jiangsu) Mesalamine Product Portfolio
6.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
6.15 Xinxiang Tianfeng Fine Chemical
6.15.1 Xinxiang Tianfeng Fine Chemical Company Information
6.15.2 Xinxiang Tianfeng Fine Chemical Description and Business Overview
6.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio
6.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesalamine Industry Chain Analysis
7.2 Mesalamine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesalamine Production Mode & Process
7.4 Mesalamine Sales and Marketing
7.4.1 Mesalamine Sales Channels
7.4.2 Mesalamine Distributors
7.5 Mesalamine Customers
8 Mesalamine Market Dynamics
8.1 Mesalamine Industry Trends
8.2 Mesalamine Market Drivers
8.3 Mesalamine Market Challenges
8.4 Mesalamine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Syntese A/S
Divis Laboratories
Ipca Laboratories
Hangzhou Brother
PharmaZell GmbH
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Cambrex Corporation
Chemi SPA
List of Tables
 Table 1. Global Mesalamine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Mesalamine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Mesalamine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Mesalamine Sales (Tons) of Key Manufacturers (2019-2024)
 Table 5. Global Mesalamine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Mesalamine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Mesalamine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Mesalamine Average Price (US$/kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Mesalamine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mesalamine, Product Type & Application
 Table 12. Global Key Manufacturers of Mesalamine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mesalamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mesalamine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Mesalamine Sales by Region (2019-2024) & (Tons)
 Table 18. Global Mesalamine Sales Market Share by Region (2019-2024)
 Table 19. Global Mesalamine Sales by Region (2025-2030) & (Tons)
 Table 20. Global Mesalamine Sales Market Share by Region (2025-2030)
 Table 21. Global Mesalamine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Mesalamine Revenue Market Share by Region (2019-2024)
 Table 23. Global Mesalamine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Mesalamine Revenue Market Share by Region (2025-2030)
 Table 25. North America Mesalamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Mesalamine Sales by Country (2019-2024) & (Tons)
 Table 27. North America Mesalamine Sales by Country (2025-2030) & (Tons)
 Table 28. North America Mesalamine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Mesalamine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Mesalamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Mesalamine Sales by Country (2019-2024) & (Tons)
 Table 32. Europe Mesalamine Sales by Country (2025-2030) & (Tons)
 Table 33. Europe Mesalamine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Mesalamine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Mesalamine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Mesalamine Sales by Region (2019-2024) & (Tons)
 Table 37. Asia Pacific Mesalamine Sales by Region (2025-2030) & (Tons)
 Table 38. Asia Pacific Mesalamine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Mesalamine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Mesalamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Mesalamine Sales by Country (2019-2024) & (Tons)
 Table 42. Latin America Mesalamine Sales by Country (2025-2030) & (Tons)
 Table 43. Latin America Mesalamine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Mesalamine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Mesalamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Mesalamine Sales by Country (2019-2024) & (Tons)
 Table 47. Middle East and Africa Mesalamine Sales by Country (2025-2030) & (Tons)
 Table 48. Middle East and Africa Mesalamine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Mesalamine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Mesalamine Sales (Tons) by Type (2019-2024)
 Table 51. Global Mesalamine Sales (Tons) by Type (2025-2030)
 Table 52. Global Mesalamine Sales Market Share by Type (2019-2024)
 Table 53. Global Mesalamine Sales Market Share by Type (2025-2030)
 Table 54. Global Mesalamine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Mesalamine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Mesalamine Revenue Market Share by Type (2019-2024)
 Table 57. Global Mesalamine Revenue Market Share by Type (2025-2030)
 Table 58. Global Mesalamine Price (US$/kg) by Type (2019-2024)
 Table 59. Global Mesalamine Price (US$/kg) by Type (2025-2030)
 Table 60. Global Mesalamine Sales (Tons) by Application (2019-2024)
 Table 61. Global Mesalamine Sales (Tons) by Application (2025-2030)
 Table 62. Global Mesalamine Sales Market Share by Application (2019-2024)
 Table 63. Global Mesalamine Sales Market Share by Application (2025-2030)
 Table 64. Global Mesalamine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Mesalamine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Mesalamine Revenue Market Share by Application (2019-2024)
 Table 67. Global Mesalamine Revenue Market Share by Application (2025-2030)
 Table 68. Global Mesalamine Price (US$/kg) by Application (2019-2024)
 Table 69. Global Mesalamine Price (US$/kg) by Application (2025-2030)
 Table 70. PharmaZell Company Information
 Table 71. PharmaZell Description and Business Overview
 Table 72. PharmaZell Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 73. PharmaZell Mesalamine Product
 Table 74. PharmaZell Recent Developments/Updates
 Table 75. Syntese A/S Company Information
 Table 76. Syntese A/S Description and Business Overview
 Table 77. Syntese A/S Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 78. Syntese A/S Mesalamine Product
 Table 79. Syntese A/S Recent Developments/Updates
 Table 80. Cambrex Corporation Company Information
 Table 81. Cambrex Corporation Description and Business Overview
 Table 82. Cambrex Corporation Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 83. Cambrex Corporation Mesalamine Product
 Table 84. Cambrex Corporation Recent Developments/Updates
 Table 85. Divis Laboratories Company Information
 Table 86. Divis Laboratories Description and Business Overview
 Table 87. Divis Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 88. Divis Laboratories Mesalamine Product
 Table 89. Divis Laboratories Recent Developments/Updates
 Table 90. Chemi SpA Company Information
 Table 91. Chemi SpA Description and Business Overview
 Table 92. Chemi SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 93. Chemi SpA Mesalamine Product
 Table 94. Chemi SpA Recent Developments/Updates
 Table 95. Ipca Laboratories Company Information
 Table 96. Ipca Laboratories Description and Business Overview
 Table 97. Ipca Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 98. Ipca Laboratories Mesalamine Product
 Table 99. Ipca Laboratories Recent Developments/Updates
 Table 100. Hangzhou Brother Company Information
 Table 101. Hangzhou Brother Description and Business Overview
 Table 102. Hangzhou Brother Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 103. Hangzhou Brother Mesalamine Product
 Table 104. Hangzhou Brother Recent Developments/Updates
 Table 105. Lianyungang Fengheng Biopharm Company Information
 Table 106. Lianyungang Fengheng Biopharm Description and Business Overview
 Table 107. Lianyungang Fengheng Biopharm Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 108. Lianyungang Fengheng Biopharm Mesalamine Product
 Table 109. Lianyungang Fengheng Biopharm Recent Developments/Updates
 Table 110. Lasa Loboratory Company Information
 Table 111. Lasa Loboratory Description and Business Overview
 Table 112. Lasa Loboratory Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 113. Lasa Loboratory Mesalamine Product
 Table 114. Lasa Loboratory Recent Developments/Updates
 Table 115. Corden Pharma Bergamo Company Information
 Table 116. Corden Pharma Bergamo Description and Business Overview
 Table 117. Corden Pharma Bergamo Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 118. Corden Pharma Bergamo Mesalamine Product
 Table 119. Corden Pharma Bergamo Recent Developments/Updates
 Table 120. Erregierre SpA Company Information
 Table 121. Erregierre SpA Description and Business Overview
 Table 122. Erregierre SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 123. Erregierre SpA Mesalamine Product
 Table 124. Erregierre SpA Recent Developments/Updates
 Table 125. CTX Lifescience Company Information
 Table 126. CTX Lifescience Description and Business Overview
 Table 127. CTX Lifescience Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 128. CTX Lifescience Mesalamine Product
 Table 129. CTX Lifescience Recent Developments/Updates
 Table 130. Ishita Active Pharma Ingredients Company Information
 Table 131. Ishita Active Pharma Ingredients Description and Business Overview
 Table 132. Ishita Active Pharma Ingredients Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 133. Ishita Active Pharma Ingredients Mesalamine Product
 Table 134. Ishita Active Pharma Ingredients Recent Developments/Updates
 Table 135. YC Biotech (Jiangsu) Company Information
 Table 136. YC Biotech (Jiangsu) Description and Business Overview
 Table 137. YC Biotech (Jiangsu) Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 138. YC Biotech (Jiangsu) Mesalamine Product
 Table 139. YC Biotech (Jiangsu) Recent Developments/Updates
 Table 140. Xinxiang Tianfeng Fine Chemical Company Information
 Table 141. Xinxiang Tianfeng Fine Chemical Description and Business Overview
 Table 142. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 143. Xinxiang Tianfeng Fine Chemical Mesalamine Product
 Table 144. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Mesalamine Distributors List
 Table 148. Mesalamine Customers List
 Table 149. Mesalamine Market Trends
 Table 150. Mesalamine Market Drivers
 Table 151. Mesalamine Market Challenges
 Table 152. Mesalamine Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mesalamine
 Figure 2. Global Mesalamine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Mesalamine Market Share by Type: 2023 & 2030
 Figure 4. Purity ≥ 97% Product Picture
 Figure 5. Purity ≥ 98% Product Picture
 Figure 6. Purity ≥ 99% Product Picture
 Figure 7. Global Mesalamine Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Mesalamine Market Share by Application: 2023 & 2030
 Figure 9. Tablets
 Figure 10. Capsules
 Figure 11. Granule
 Figure 12. Suppository
 Figure 13. Enema
 Figure 14. Others
 Figure 15. Global Mesalamine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Mesalamine Market Size (2019-2030) & (US$ Million)
 Figure 17. Global Mesalamine Sales (2019-2030) & (Tons)
 Figure 18. Global Mesalamine Average Price (US$/kg) & (2019-2030)
 Figure 19. Mesalamine Report Years Considered
 Figure 20. Mesalamine Sales Share by Manufacturers in 2023
 Figure 21. Global Mesalamine Revenue Share by Manufacturers in 2023
 Figure 22. Global 5 and 10 Largest Mesalamine Players: Market Share by Revenue in Mesalamine in 2023
 Figure 23. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 24. Global Mesalamine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 25. North America Mesalamine Sales Market Share by Country (2019-2030)
 Figure 26. North America Mesalamine Revenue Market Share by Country (2019-2030)
 Figure 27. U.S. Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Canada Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Europe Mesalamine Sales Market Share by Country (2019-2030)
 Figure 30. Europe Mesalamine Revenue Market Share by Country (2019-2030)
 Figure 31. Germany Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. France Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. U.K. Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Italy Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Russia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Asia Pacific Mesalamine Sales Market Share by Region (2019-2030)
 Figure 37. Asia Pacific Mesalamine Revenue Market Share by Region (2019-2030)
 Figure 38. China Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Japan Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. South Korea Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. India Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Australia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Taiwan Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Indonesia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Thailand Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Malaysia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Philippines Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Latin America Mesalamine Sales Market Share by Country (2019-2030)
 Figure 49. Mexico Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Brazil Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Argentina Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Middle East and Africa Mesalamine Sales Market Share by Country (2019-2030)
 Figure 53. Middle East and Africa Mesalamine Revenue Market Share by Country (2019-2030)
 Figure 54. Turkey Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Saudi Arabia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. UAE Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. Global Sales Market Share of Mesalamine by Type (2019-2030)
 Figure 58. Global Revenue Market Share of Mesalamine by Type (2019-2030)
 Figure 59. Global Mesalamine Price (US$/kg) by Type (2019-2030)
 Figure 60. Global Sales Market Share of Mesalamine by Application (2019-2030)
 Figure 61. Global Revenue Market Share of Mesalamine by Application (2019-2030)
 Figure 62. Global Mesalamine Price (US$/kg) by Application (2019-2030)
 Figure 63. Mesalamine Value Chain
 Figure 64. Mesalamine Production Process
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions